Posted inBusiness Tax Plan Details Muddle GOP Agenda by Carolyn Y. Johnson The Washington Post, and Mike DeBonis The Washington PostOctober 1, 2017
Posted inUncategorized OK, Now What? by Juliet Eilperin The Washington Post, and Carolyn Y. Johnson The Washington PostJuly 29, 2017
Posted inUncategorized Sanders Bill to Allow Drug Imports Takes Swing at Big Pharma by Carolyn Y. Johnson The Washington PostMarch 1, 2017
Posted inUncategorized Judge Blocks $54 Billion Health Insurance Merger by Carolyn Y. Johnson The Washington PostFebruary 9, 2017
Posted inUncategorized Judge: Insurer Misled on Exchanges by Carolyn Y. Johnson The Washington PostJanuary 24, 2017
Posted inUncategorized Poll: Only 1 in 5 Americans Supports GOP ‘Repeal and Delay’ of Health Law by Carolyn Y. Johnson The Washington PostJanuary 6, 2017
Posted inUncategorized Report Says Mylan’s EpiPen Profits 60 Percent More Than It Told Congress by Carolyn Y. Johnson The Washington PostSeptember 26, 2016
Posted inUncategorized EpiPen Maker To Release Generic Drug by Carolyn Y. Johnson Washington PostAugust 29, 2016
Posted inUncategorized Insurer Aetna Pulls Out of Health Exchanges by Carolyn Y. Johnson Washington PostAugust 17, 2016
